相似文献
1
Genetic polymorphisms and statin therapy.
JAMA. 2004 Sep 15;292(11):1302-3. doi: 10.1001/jama.292.11.1302-b.
2
Pharmacogenetic study of statin therapy and cholesterol reduction.
Curr Atheroscler Rep. 2005 May;7(3):177-8.
3
Pharmacogenetic study of statin therapy and cholesterol reduction.
JAMA. 2004 Jun 16;291(23):2821-7. doi: 10.1001/jama.291.23.2821.
4
APOE gene polymorphisms and response to statin therapy.
Pharmacogenomics J. 2009 Aug;9(4):248-57. doi: 10.1038/tpj.2009.25. Epub 2009 Jun 16.
5
New guidelines in statin therapy.
Plast Surg Nurs. 2005 Apr-Jun;25(2):109-10. doi: 10.1097/00006527-200504000-00012.
6
[HMG-CoA reductase inhibitors].
Nihon Rinsho. 2001 Mar;59 Suppl 3:578-86.
7
Cholesterol--frequently asked questions.
Aust Fam Physician. 2006 Aug;35(8):595-6.
8
Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins.
Pharmacogenomics. 2010 Mar;11(3):309-17. doi: 10.2217/pgs.09.160.
9
Lipid management with statins. The lower the better?
Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y.
10
SNP of HMGCR and Apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan.
Pak J Pharm Sci. 2021 Jul;34(4(Supplementary)):1577-1583.
Zotero 插件